Form 4: SOPHIA GENETICS SA: Officer Sells Shares for Tax Withholding

SOPHIA GENETICS SA reports that Chief Legal Officer Daan van Well sold 2,400 ordinary shares to cover tax obligations related to vested restricted stock units, executed under a Rule 10b5-1 trading plan.

Summary

• Daan van Well, Chief Legal Officer of SOPHiA GENETICS SA, sold 2,400 ordinary shares on April 10, 2026.
• The sale was conducted to satisfy tax withholding obligations stemming from the vesting of restricted stock units on April 2 and 3, 2026.
• These transactions were executed under a pre-established Rule 10b5-1(c) trading plan, indicating they were not discretionary.
• The shares were sold at a weighted average price of $4.6672, with individual sale prices ranging from $4.61 to $4.77.
• Following the sale, Mr. van Well beneficially owns 346,420 ordinary shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While it involves an insider selling shares, the clear explanation of it being for tax withholding under a Rule 10b5-1 plan mitigates negative sentiment.

Positives

• The sale was executed under a Rule 10b5-1(c) trading plan, which is designed to comply with insider trading regulations and provides an affirmative defense against allegations of insider trading.
• The transaction was solely to cover tax withholding obligations, suggesting it was a necessary administrative action rather than a reflection of negative sentiment towards the company's stock.

Negatives

• A reduction in the beneficial ownership of a key executive, even if for tax purposes, can sometimes be perceived negatively by the market.
• The sale represents a disposal of company stock by an insider.

Risks

• While the sale was part of a pre-arranged plan for tax purposes, any significant selling by insiders can create downward pressure on the stock price.
• The company's stock performance may be influenced by the perception of insider selling, regardless of the stated reason.

Future Outlook

No specific future outlook or guidance is provided in this filing, as it pertains to a change in beneficial ownership by an officer.

Management Comments

• Sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.
• The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures for insider transactions. The key aspect here is the sale being conducted under a Rule 10b5-1 plan for tax withholding, a common and generally accepted practice that aims to mitigate concerns about opportunistic insider selling.

Stakeholder Impact

• Shareholders: May perceive insider selling, though the tax-related nature and Rule 10b5-1 plan mitigate significant concern.
• Employees: The transaction highlights the equity compensation practices and tax implications for executives.
• Management: Demonstrates adherence to regulatory disclosure requirements for beneficial ownership changes.

Next Steps

• The company may receive written requests for further information regarding the specific sale prices from the issuer, security holders, or the SEC staff.
• The reporting person will continue to hold 346,420 ordinary shares.

Key Dates

Keywords

SOPHiA GENETICS SA, Form 4, Insider Trading, Stock Sale, Tax Withholding, Restricted Stock Units, Rule 10b5-1, Daan van Well, Chief Legal Officer, Beneficial Ownership